Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
A 329.69 3.58% 11.38
ABMD closed up 3.58 percent on Friday, January 15, 2021, on 1.42 times normal volume. The bulls were able to push the stock to a new 52-week high.
Earnings due: Feb 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ABMD trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Reversal New Highs Setup Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Outside Day Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 3.58%
Overbought Stochastic Strength 3.58%
NR7 Range Contraction 1.85%
Older End-of-Day Signals for ABMD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ABIOMED, Inc. Description

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Catheter Heart Failure Cardiology Prosthetics Circulatory System Interventional Cardiology Percutaneous Heart Attack Heart Diseases Heart Surgery Acute Heart Failure

Is ABMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 333.66
52 Week Low 119.0101
Average Volume 269,603
200-Day Moving Average 259.33
50-Day Moving Average 287.59
20-Day Moving Average 314.62
10-Day Moving Average 322.95
Average True Range 10.03
ADX 32.24
+DI 27.12
-DI 12.30
Chandelier Exit (Long, 3 ATRs ) 303.57
Chandelier Exit (Short, 3 ATRs ) 293.00
Upper Bollinger Band 340.27
Lower Bollinger Band 288.98
Percent B (%b) 0.79
BandWidth 16.30
MACD Line 11.75
MACD Signal Line 12.20
MACD Histogram -0.4557
Fundamentals Value
Market Cap 14.9 Billion
Num Shares 45.2 Million
EPS 4.55
Price-to-Earnings (P/E) Ratio 72.46
Price-to-Sales 15.44
Price-to-Book 10.39
PEG Ratio 2.75
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 355.78
Resistance 3 (R3) 354.21 343.93 351.43
Resistance 2 (R2) 343.93 337.29 344.72 349.98
Resistance 1 (R1) 336.81 333.18 340.37 338.39 348.53
Pivot Point 326.54 326.54 328.32 327.33 326.54
Support 1 (S1) 319.42 319.89 322.98 320.99 310.85
Support 2 (S2) 309.14 315.79 309.93 309.40
Support 3 (S3) 302.02 309.14 307.95
Support 4 (S4) 303.60